Osman Manavoglu
Overview
Explore the profile of Osman Manavoglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deligonul A, Evrensel T, Avci N, Ugras N, Ture M, Cubukcu E, et al.
J BUON
. 2016 Aug;
21(3):564-9.
PMID: 27569073
Purpose: The clinical value of HER4 - a cell surface receptor that belongs to the human epidermal growth factor receptor family - for predicting survival outcomes in patients with breast...
2.
Cubukcu E, Olmez O, Ozkan K, Pekgoz M, Ugras N, Deligonul A, et al.
Turk J Gastroenterol
. 2015 Apr;
25 Suppl 1:295-6.
PMID: 25910348
No abstract available.
3.
Aykan N, Yalcin S, Turhal N, Ozdogan M, Demir G, Ozkan M, et al.
Turk J Gastroenterol
. 2015 Apr;
26(2):145-53.
PMID: 25835113
Background/aims: This study aimed to determine the epidemiological characteristics of colorectal cancer in Turkey. Materials And Methods: In this multicenter, prospective, and cross-sectional registry study, data for 968 patients with...
4.
Canhoroz M, Kanat O, Saraydaroglu O, Buluc E, Avci N, Cubukcu E, et al.
J Cancer Res Ther
. 2014 Jul;
10(2):347-53.
PMID: 25022390
Purpose: Surgery is the definitive treatment for early colon cancers. Adjuvant therapies are used with the aim of eradicating micrometastases and improving cure rates. Recent studies have proposed that adiponectin...
5.
Cubukcu E, Olmez O, Kanat O, Kabul S, Canhoroz M, Avci N, et al.
Contemp Oncol (Pozn)
. 2014 May;
18(1):34-8.
PMID: 24876819
Introduction: Triple-negative breast cancers (TNBCs) - which lack the expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER-2) - have no established markers...
6.
Hartavi M, Kurt E, Oral B, Olmez O, Cubukcu E, Deligonul A, et al.
Asian Pac J Cancer Prev
. 2014 Jan;
14(12):7583-6.
PMID: 24460337
Background: Suppressor of cytokine signaling (SOCS)-1 acts as a key regulator of many cytokine signaling pathways and its abnormal expression has been identified in several human malignancies, suggesting potential roles...
7.
Olmez O, Evrensel T, Cubukcu E, Ugras N, Avci N, Canhoroz M, et al.
Asian Pac J Cancer Prev
. 2013 Sep;
14(7):4115-9.
PMID: 23991962
Background: Previous reports have shown that human epidermal receptor (HER)-3 overexpression may be associated with poor prognosis in patients with breast cancer, but results have been conflicting. In this study,...
8.
Olmez O, Cubukcu E, Evrensel T, Kanat O, Kurt E, Akyildiz E, et al.
Onkologie
. 2012 Oct;
35(10):604-6.
PMID: 23038234
Background: Pulmonary actinomycosis may create a diagnostic and therapeutic dilemma especially in cancer patients. Case Report: A 64-year-old male patient presented with a productive cough, bloody sputum, and weight loss....
9.
Bayrak M, Olmez O, Kurt E, Cubukcu E, Evrensel T, Kanat O, et al.
Clin Transl Oncol
. 2012 Aug;
15(4):307-12.
PMID: 22911549
Background: Overexpression of the gene c-erbB2, which encodes a receptor tyrosine kinase, has been associated with prognosis and response to therapy in several solid tumors. This study was designed to...
10.
Kanat O, Kilickap S, Korkmaz T, Ustaalioglu Oven B, Canhoroz M, Cubukcu E, et al.
Tumori
. 2011 Oct;
97(4):473-8.
PMID: 21989436
Aims And Background: The aim of the study was to analyze the clinicopathological characteristics, treatment modalities, and clinical outcome of patients with primary small cell carcinoma of the breast. Methods:...